- Home
- KNW
KNW
Know Labs Inc.
as 05-31-2024 4:00pm EST
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 53.4M | IPO Year: | N/A |
| Target Price: | $1.00 | AVG Volume (30 days): | 94.0K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.23 - $1.48 | Next Earning Date: | 05-15-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Know Labs Inc. News
KNW Breaking Stock News: Dive into KNW Ticker-Specific Updates for Smart Investing
Business Wire
17 days ago
Know Labs Appoints Chris Somogyi as President, International
GuruFocus.com
17 days ago
Know Labs Inc (KNW) Q2 2024 Earnings Call Transcript Highlights: Strategic Developments Amid ...
Business Wire
18 days ago
Know Labs, Inc. Reports Second Quarter FY 2024 Results
Business Wire
24 days ago
Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting
Business Wire
25 days ago
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024
Business Wire
2 months ago
Know Labs to Present Clinical Research at the 2024 American Physiology Summit
Business Wire
3 months ago
Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study
Business Wire
3 months ago
Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives
Share on Social Networks:
Disclaimer
The information presented on this page, "KNW Know Labs Inc. - Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.